Member Info for soulac

Looking strong, just need to break 3p,

This is about to break out, placing cleared, imo

Bloody predictive text

https://clearcapitalmarkets.co.uk/cykel-ai-report/?gad_source=1&gbraid=0AAAAAobxwxZstWC2T1FClRTKeOoBtakAy&gclid=EAIaIQobChMIk_n-pMOXigMVPJhQBh0ZoQAzEAAYAiAAEgJdrfD_BwE

Blockers note , put this at 62p this year,

If this breaks out it will be a big rises

Https://www.lse.co.uk/media/TRLS/what-s-hot-14-01-25-ig50a4s6rxlkbnj.html

It’s moving at last,

Lol, ceo takes shares at 12p and they be careful,

I thinks he’s there to work on a new part of the business,

We will have to wait and see,

What would really screw with the derampers heads, is if he starts to buy ,

Wait till the asian market, get hold of this,

He mentioned new technologies and taking them to market and creating real value,

AI for medical diagnosis, that’s his speciality,

One stiff that we are moving into this sector we will be in the £££££

Imo

This could be the start of sustained news flow,

And dare I say it just the start for the company, gla

Https://x.com/StockBoxMedia/status/1881271245120966682?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet

Bringing in the big boys, RNS out

Dr. Thomas Sawyer is an accomplished executive and thought leader with extensive experience in biotechnology, medical technology, AI, and data-driven innovation. With a proven track record of success at senior management and board levels across public and private sectors, Dr. Sawyer specializes in identifying high-potential technologies and driving business growth through innovative strategies and partnerships.

Dr. Sawyer's expertise encompasses corporate strategy, financing, IPO execution, and fostering collaborations across the technology, global healthcare systems and biopharma sectors.

Dr. Sawyer holds a PhD in Life Sciences from the University of Glasgow and an Executive MBA from the University of Cambridge. Over his career, he has served in senior executive roles in both public and private companies, successfully driving technological innovations and fostering partnerships across the UK, EU, USA, and APAC regions. His academic affiliations include an honorary lecturer at the University College London and mentorship at the Judge Business School at the University of Cambridge.

Dr. Sawyer combines technical expertise and strategic vision to bridge the gap between technology and business. His leadership philosophy emphasizes adaptability, stakeholder alignment, and scalable solutions for complex business challenges.

Got a good feeling about today, imo

Should clear the path for a good rise today, volume up

Looks like MMs just took out a lot of limit orders,

Not 100% I got the right person,

He is director of this company.

Sale last year , 520 million

https://www.marketscreener.com/quote/stock/SANVO-FINE-CHEMICALS-GROU-103501749/news/SANVO-Fine-Chemicals-Group-Limited-Reports-Earnings-Results-for-the-Half-Year-Ended-June-30-2024-47780366/

Https://www.marketscreener.com/insider/CHEUK-LUN-NG-A1MUW2/

Not sure if that’s him, that from 2014

Https://www.hkexnews.hk/listedco/listconews/sehk/2018/0611/ltn20180611309.pdf

Mr. Ng Cheuk Lun ("Mr. Ng'")

Mr. Ng, aged 37, was nominated and appointed as an independent non-executive Director by the Shareholders on 9 October 2014. Mr. Ng is also the chairman of the remuneration committee, a member of the audit committee and nomination committee of the Board. Mr. Ng is a member of Hong Kong Institute of Certified Public Accountants and CPA Australia. Mr. Ng has extensive experience in financial reporting for listed companies and public securities offering and mergers and acquisitions in Hong Kong and abroad.

Mr. Ng is currently a practicing accountant at MN CPA Limited. Prior to joining MN CPA Limited, Mr. Ng worked at notable international accounting firms as well as multinational corporations in Hong Kong and Australia for over 13 years.